Investigation of radiosensitivity gene signatures in cancer cell linesCitation formats

  • External authors:
  • John S. Hall
  • Rohan Iype
  • Joana Senra
  • Janet Taylor
  • Lucile Armenoult
  • Kenneth Oguejiofor
  • Yaoyong Li
  • Peter L. Stern
  • Mark J. O'Connor
  • Crispin J. Miller

Standard

Investigation of radiosensitivity gene signatures in cancer cell lines. / Hall, John S.; Iype, Rohan; Senra, Joana; Taylor, Janet; Armenoult, Lucile; Oguejiofor, Kenneth; Li, Yaoyong; Stratford, Ian; Stern, Peter L.; O'Connor, Mark J.; Miller, Crispin J.; West, Catharine M L.

In: PLoS ONE, Vol. 9, No. 1, e86329, 22.01.2014.

Research output: Contribution to journalArticlepeer-review

Harvard

Hall, JS, Iype, R, Senra, J, Taylor, J, Armenoult, L, Oguejiofor, K, Li, Y, Stratford, I, Stern, PL, O'Connor, MJ, Miller, CJ & West, CML 2014, 'Investigation of radiosensitivity gene signatures in cancer cell lines', PLoS ONE, vol. 9, no. 1, e86329. https://doi.org/10.1371/journal.pone.0086329, https://doi.org/10.1371/journal.pone.0086329, https://doi.org/10.1371/journal.pone.0086329

APA

Hall, J. S., Iype, R., Senra, J., Taylor, J., Armenoult, L., Oguejiofor, K., Li, Y., Stratford, I., Stern, P. L., O'Connor, M. J., Miller, C. J., & West, C. M. L. (2014). Investigation of radiosensitivity gene signatures in cancer cell lines. PLoS ONE, 9(1), [e86329]. https://doi.org/10.1371/journal.pone.0086329, https://doi.org/10.1371/journal.pone.0086329, https://doi.org/10.1371/journal.pone.0086329

Vancouver

Author

Hall, John S. ; Iype, Rohan ; Senra, Joana ; Taylor, Janet ; Armenoult, Lucile ; Oguejiofor, Kenneth ; Li, Yaoyong ; Stratford, Ian ; Stern, Peter L. ; O'Connor, Mark J. ; Miller, Crispin J. ; West, Catharine M L. / Investigation of radiosensitivity gene signatures in cancer cell lines. In: PLoS ONE. 2014 ; Vol. 9, No. 1.

Bibtex

@article{080a751fc25149488e7052bdbd2b0d78,
title = "Investigation of radiosensitivity gene signatures in cancer cell lines",
abstract = "Intrinsic radiosensitivity is an important factor underlying radiotherapy response, but there is no method for its routine assessment in human tumours. Gene signatures are currently being derived and some were previously generated by expression profiling the NCI-60 cell line panel. It was hypothesised that focusing on more homogeneous tumour types would be a better approach. Two cell line cohorts were used derived from cervix [n = 16] and head and neck [n = 11] cancers. Radiosensitivity was measured as surviving fraction following irradiation with 2 Gy (SF2) by clonogenic assay. Differential gene expression between radiosensitive and radioresistant cell lines (SF2〈/〉. median) was investigated using Affymetrix GeneChip Exon 1.0ST (cervix) or U133A Plus2 (head and neck) arrays. There were differences within cell line cohorts relating to tissue of origin reflected by expression of the stratified epithelial marker p63. Of 138 genes identified as being associated with SF2, only 2 (1.4%) were congruent between the cervix and head and neck carcinoma cell lines (MGST1 and TFPI), and these did not partition the published NCI-60 cell lines based on SF2. There was variable success in applying three published radiosensitivity signatures to our cohorts. One gene signature, originally trained on the NCI-60 cell lines, did partially separate sensitive and resistant cell lines in all three cell line datasets. The findings do not confirm our hypothesis but suggest that a common transcriptional signature can reflect the radiosensitivity of tumours of heterogeneous origins. {\textcopyright} 2014 Hall et al.",
author = "Hall, {John S.} and Rohan Iype and Joana Senra and Janet Taylor and Lucile Armenoult and Kenneth Oguejiofor and Yaoyong Li and Ian Stratford and Stern, {Peter L.} and O'Connor, {Mark J.} and Miller, {Crispin J.} and West, {Catharine M L}",
note = "GO801525, Medical Research Council, United Kingdom",
year = "2014",
month = jan,
day = "22",
doi = "10.1371/journal.pone.0086329",
language = "English",
volume = "9",
journal = "PL o S One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

RIS

TY - JOUR

T1 - Investigation of radiosensitivity gene signatures in cancer cell lines

AU - Hall, John S.

AU - Iype, Rohan

AU - Senra, Joana

AU - Taylor, Janet

AU - Armenoult, Lucile

AU - Oguejiofor, Kenneth

AU - Li, Yaoyong

AU - Stratford, Ian

AU - Stern, Peter L.

AU - O'Connor, Mark J.

AU - Miller, Crispin J.

AU - West, Catharine M L

N1 - GO801525, Medical Research Council, United Kingdom

PY - 2014/1/22

Y1 - 2014/1/22

N2 - Intrinsic radiosensitivity is an important factor underlying radiotherapy response, but there is no method for its routine assessment in human tumours. Gene signatures are currently being derived and some were previously generated by expression profiling the NCI-60 cell line panel. It was hypothesised that focusing on more homogeneous tumour types would be a better approach. Two cell line cohorts were used derived from cervix [n = 16] and head and neck [n = 11] cancers. Radiosensitivity was measured as surviving fraction following irradiation with 2 Gy (SF2) by clonogenic assay. Differential gene expression between radiosensitive and radioresistant cell lines (SF2〈/〉. median) was investigated using Affymetrix GeneChip Exon 1.0ST (cervix) or U133A Plus2 (head and neck) arrays. There were differences within cell line cohorts relating to tissue of origin reflected by expression of the stratified epithelial marker p63. Of 138 genes identified as being associated with SF2, only 2 (1.4%) were congruent between the cervix and head and neck carcinoma cell lines (MGST1 and TFPI), and these did not partition the published NCI-60 cell lines based on SF2. There was variable success in applying three published radiosensitivity signatures to our cohorts. One gene signature, originally trained on the NCI-60 cell lines, did partially separate sensitive and resistant cell lines in all three cell line datasets. The findings do not confirm our hypothesis but suggest that a common transcriptional signature can reflect the radiosensitivity of tumours of heterogeneous origins. © 2014 Hall et al.

AB - Intrinsic radiosensitivity is an important factor underlying radiotherapy response, but there is no method for its routine assessment in human tumours. Gene signatures are currently being derived and some were previously generated by expression profiling the NCI-60 cell line panel. It was hypothesised that focusing on more homogeneous tumour types would be a better approach. Two cell line cohorts were used derived from cervix [n = 16] and head and neck [n = 11] cancers. Radiosensitivity was measured as surviving fraction following irradiation with 2 Gy (SF2) by clonogenic assay. Differential gene expression between radiosensitive and radioresistant cell lines (SF2〈/〉. median) was investigated using Affymetrix GeneChip Exon 1.0ST (cervix) or U133A Plus2 (head and neck) arrays. There were differences within cell line cohorts relating to tissue of origin reflected by expression of the stratified epithelial marker p63. Of 138 genes identified as being associated with SF2, only 2 (1.4%) were congruent between the cervix and head and neck carcinoma cell lines (MGST1 and TFPI), and these did not partition the published NCI-60 cell lines based on SF2. There was variable success in applying three published radiosensitivity signatures to our cohorts. One gene signature, originally trained on the NCI-60 cell lines, did partially separate sensitive and resistant cell lines in all three cell line datasets. The findings do not confirm our hypothesis but suggest that a common transcriptional signature can reflect the radiosensitivity of tumours of heterogeneous origins. © 2014 Hall et al.

U2 - 10.1371/journal.pone.0086329

DO - 10.1371/journal.pone.0086329

M3 - Article

C2 - 24466029

VL - 9

JO - PL o S One

JF - PL o S One

SN - 1932-6203

IS - 1

M1 - e86329

ER -